Timo Gaiser
Papers
1
Total Citations
40
H-Index
1
About
Dr. Timo Gaiser is a leading pathologist and translational researcher whose work centers on the molecular characterization of ovarian and gastrointestinal cancers, with a particular focus on homologous recombination deficiency (HRD) as a predictive biomarker. His major contributions include the diagnostic evaluation of HRD in a real-world cohort of 514 ovarian carcinoma samples, employing next-generation sequencing to analyze BRCA1/BRCA2 and over 26,000 single-nucleotide polymorphisms. This landmark study, cited over 40 times, has been instrumental in defining targeted therapy strategies for ovarian cancer patients, directly impacting clinical decision-making. Dr. Gaiser’s research bridges the gap between molecular pathology and precision oncology, providing critical insights into how genomic instability can guide treatment. His work is widely recognized for its translational relevance, helping to refine patient stratification for PARP inhibitor therapies. Through rigorous, large-scale genomic analyses, Dr. Gaiser continues to advance the field of cancer biomarker discovery, making his research essential reading for clinicians and scientists working to improve outcomes in gynecologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1